Effect of lovastatin pre-treatment on viability at clinically attainable concentrations
(A) Viability as assessed by Trypan blue staining: HL60 cells were treated with 1, 3 or 12 mM lovastatin on Day 0. Mevalonate (200 mM) was added to the cells on day 1, 2, 3, 4 or 5. The effects on viability determined on day 6 as measured by cell counts and Trypan blue uptake. ¼ 2; one example is sh...
Gespeichert in:
Hauptverfasser: | , |
---|---|
Format: | Bild |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!